[go: up one dir, main page]

FR2899585B1 - Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium - Google Patents

Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium

Info

Publication number
FR2899585B1
FR2899585B1 FR0602975A FR0602975A FR2899585B1 FR 2899585 B1 FR2899585 B1 FR 2899585B1 FR 0602975 A FR0602975 A FR 0602975A FR 0602975 A FR0602975 A FR 0602975A FR 2899585 B1 FR2899585 B1 FR 2899585B1
Authority
FR
France
Prior art keywords
compounds
coupled
biological target
recognition
complexing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0602975A
Other languages
English (en)
Other versions
FR2899585A1 (fr
Inventor
Marc Port
Claire Corot
Thierry Gautheret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guerbet SA
Original Assignee
Guerbet SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0602975A priority Critical patent/FR2899585B1/fr
Application filed by Guerbet SA filed Critical Guerbet SA
Priority to PCT/EP2006/067211 priority patent/WO2007042504A2/fr
Priority to JP2008534028A priority patent/JP5368099B2/ja
Priority to EP06807097.8A priority patent/EP1940841B9/fr
Priority to US12/083,269 priority patent/US8926945B2/en
Priority to CA2625196A priority patent/CA2625196C/fr
Publication of FR2899585A1 publication Critical patent/FR2899585A1/fr
Priority to US13/205,352 priority patent/US8986650B2/en
Application granted granted Critical
Publication of FR2899585B1 publication Critical patent/FR2899585B1/fr
Priority to JP2013107700A priority patent/JP5706926B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR0602975A 2005-10-07 2006-04-05 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium Expired - Fee Related FR2899585B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0602975A FR2899585B1 (fr) 2006-04-05 2006-04-05 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
JP2008534028A JP5368099B2 (ja) 2005-10-07 2006-10-09 ガリウムと錯体形成することが可能なシグナル部分にカップリングされた、生物学的標的の認識のための部分を含んでなる化合物
EP06807097.8A EP1940841B9 (fr) 2005-10-07 2006-10-09 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
US12/083,269 US8926945B2 (en) 2005-10-07 2006-10-09 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
PCT/EP2006/067211 WO2007042504A2 (fr) 2005-10-07 2006-10-09 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
CA2625196A CA2625196C (fr) 2005-10-07 2006-10-09 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
US13/205,352 US8986650B2 (en) 2005-10-07 2011-08-08 Complex folate-NOTA-Ga68
JP2013107700A JP5706926B2 (ja) 2005-10-07 2013-05-22 ガリウムと錯体形成することが可能なシグナル部分にカップリングされた、生物学的標的の認識のための部分を含んでなる化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0602975A FR2899585B1 (fr) 2006-04-05 2006-04-05 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium

Publications (2)

Publication Number Publication Date
FR2899585A1 FR2899585A1 (fr) 2007-10-12
FR2899585B1 true FR2899585B1 (fr) 2012-06-15

Family

ID=37459406

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0602975A Expired - Fee Related FR2899585B1 (fr) 2005-10-07 2006-04-05 Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium

Country Status (1)

Country Link
FR (1) FR2899585B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (de) 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molekül zur Funktionalisierung eines Trägers, Bindung eines Radionuklids an den Träger und Radionuklidgenerator zur Herstellung des Radionuklids sowie Herstellungsverfahren
WO2022064812A1 (fr) * 2020-09-28 2022-03-31 国立研究開発法人量子科学技術研究開発機構 Procédé de production d'une substance marquée radioactive, dispositif de production d'une substance marquée radioactive, et procédé d'évaporation et de concentration de nucléide métallique radioactif

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071490A (en) * 1998-05-07 2000-06-06 Immunomedics, Inc. Position emission tomography using gallium-68 chelates
US7011816B2 (en) * 2001-12-26 2006-03-14 Immunomedics, Inc. Labeling targeting agents with gallium-68 and gallium-67
CN101443051A (zh) * 2005-02-22 2009-05-27 通用电气健康护理有限公司 放射性标记镓复合物、其合成方法及其在恶性肿瘤中egfr表达的pet成像中的应用

Also Published As

Publication number Publication date
FR2899585A1 (fr) 2007-10-12

Similar Documents

Publication Publication Date Title
WO2007042504A3 (fr) Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
FR2911967B1 (fr) Systeme d'imagerie echographique.
EP1951355A4 (fr) Systeme d'injection de fluides medicaux
FR2882094B1 (fr) Systeme de commande d'assistance de suralimentation
FR2908888B1 (fr) Dispositif pour la detection exaltee de l'emission d'une particule cible
EP2084304A4 (fr) Système d'injection de trichlorure de gallium
EP1994492A4 (fr) Système d'imagerie artérielle
EP1638612A4 (fr) Agents d'imagerie a cible de cox-2
FR2886714B1 (fr) Systeme d'injection anti-rotatif pour turbo-reacteur
GB0417686D0 (en) Novel targets for inductive sensing applications
FR2881818B1 (fr) Soupape de commande d'ouverture.
PL1908349T3 (pl) Preparaty bakteriobójcze oparte na 1,2-benzizotiazolin-3-onie
EP1972639A3 (fr) Réactifs pour la détection de la phosphorylation de protéines dans des voies signalant un carcinome
FR2893229B1 (fr) Cage pour la culture aquatique de mollusques.
EP1963532A4 (fr) Methylation de l'adn en tant que cible pour le diagnostic et le traitement de la leucemie lymphocytaire chronique (llc)
FR2892808B1 (fr) Dispositif de pilotage d'un projectile.
FR2899585B1 (fr) Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
FR2888753B1 (fr) Vecteur cible avec fonction d'imagerie activable
ATE448688T1 (de) 3-amino-1,2-benzisothiazol-verbindungen zur bekämpfung von tierpest
EP2042506A4 (fr) Complexe de carbène hétérocyclique azoté d'or de phényléthynyle substitué
FR2906290B1 (fr) Systeme de fermeture d'ouvrant.
ITTO20050009A1 (it) Sistema d'illuminazione a comando remoto per ambienti.
FR2888843B1 (fr) Procede de preparation d'un diarylanthracene.
FR2908972B1 (fr) Suceur d'aspirateur.
FR2889461B1 (fr) Microtube de laboratoire.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20211205